Document is current
Any future updates will be listed below
-
Authors
Tiesmeyer, Sebastian
Müller-Bötticher, Niklas
Malt, Alexander
Ma, Leyao
Marco-Salas, Sergio https://orcid.org/0000-0002-4636-0322
Kiessling, Paul https://orcid.org/0000-0002-9794-9532
Horn, Paul https://orcid.org/0000-0002-8755-7703
Guillot, Adrien https://orcid.org/0000-0002-6002-9986
Kuemmerle, Louis B. https://orcid.org/0000-0002-9193-1243
Tacke, Frank https://orcid.org/0000-0001-6206-0226
Theis, Fabian J.
Kuppe, Christoph https://orcid.org/0000-0003-4597-9833
Nilsson, Mats https://orcid.org/0000-0001-9985-0387
Eils, Roland https://orcid.org/0000-0002-0034-4036
Long, Brian https://orcid.org/0000-0002-7793-5969
Ishaque, Naveed https://orcid.org/0000-0002-8426-901X
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (35081457)
Bundesministerium für Bildung und Forschung (031L0265)
Bundesministerium für Bildung und Forschung (01KD2443)
- License Information
-
More Information
Article History
Received: 18 December 2024
Accepted: 7 January 2026
First Online: 10 February 2026
Competing interests
: S.M.-S. is a co-founder of Spatialist, a data analysis company focused on spatial omics. P.H.’s laboratory has received research grants (funding to the institution) from MSD. P.H. has received lecture fees from AstraZeneca, Falk and Orphalan, as well as travel support from Falk, Ipsen and Boehringer Ingelheim. A.G.’s laboratory has received research grants (funding to the institution) from Agomab. F.T.’s laboratory has received research grants (funding to the institution) from Agomab, AstraZeneca, MSD and Gilead. F.T. has received honoraria for consulting or lectures from Gilead, AbbVie, Falk, AstraZeneca, Boehringer Ingelheim, Madrigal, MSD, GSK, Ipsen, Mirum, Novartis, Novo Nordisk and Sanofi. F.J.T. consults for Immunai, Singularity Bio, CytoReason and Omniscope, and holds ownership interests in Dermagnostix and Cellarity. N.I.’s laboratory has received research grants (funding to the institution) from Owkin. The other authors declare no competing interests.
